NIH-funded research R37 grant

Investigating the role of mossy cells in temporal lobe epilepsy

Official title: Mossy Cells in Temporal Lobe Epilepsy

Funded at Nathan S. Kline Institute for Psych Res · NIH-11004628 · Data updated 2026-11-12

This study is looking at special brain cells called mossy cells to see how they can both cause and help stop seizures in people with temporal lobe epilepsy, with the hope of finding new treatment options for those who don’t respond to current medications.

More Epilepsy research and trials

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionNathan S. Kline Institute for Psych Res
NIH-funded
Lab location1 site (Orangeburg, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2026
Funding year2025
Award (this year)$417,080
NIH project number5R37NS126529-03
Project IDNIH-11004628 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with temporal lobe epilepsy, especially those experiencing frequent seizures and comorbid conditions.

Less likely to help

Patients with epilepsy types other than temporal lobe epilepsy may not benefit from this research.

What this research studies

This research focuses on understanding how specific cells in the brain, known as mossy cells, function in the context of temporal lobe epilepsy (TLE). The study aims to explore the dual role of these cells during different stages of the condition, particularly how they may contribute to both seizure activity and inhibition of seizures. By examining the excitatory and inhibitory actions of mossy cells on other brain cells, researchers hope to identify new treatment strategies for patients who do not respond well to existing medications. The approach involves detailed cellular analysis and may lead to innovative therapeutic interventions.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options for patients with temporal lobe epilepsy, particularly those who currently have limited responses to medication.

How similar studies have gone: Previous research has shown promise in exploring the roles of different brain cell types in epilepsy, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Nathan S. Kline Institute for Psych Res
    Orangeburg, United States
    Active

Researchers

  • Principal investigator: Scharfman, Helen E — Nathan S. Kline Institute for Psych Res
  • Study coordinator: Scharfman, Helen E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.